This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Khamashta, M. Search for Related Content PubMed PubMed Citation Articles by Khamashta, M. Social Bookmarking                         What's this?

Review : Management of thrombosis and pregnancy loss in the antiphospholipid syndrome

Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, London SE 1 7EH, UK

More than a decade has gone by since the detailed clinical description of the Antiphospholipid (Hughes) Syndrome. Because of the wide spectrum of manifestations, virtually any physician may encounter patients with this potentially treatable condition. Because of limited controlled, prospective data, current therapy remains empirical and directed at coagulation mechanisms, immune mechanisms, or both. There is now good evidence that patients with antiphospholipid- associated thrombosis will be subject to recurrences and require prophylactic therapy. Although most authorities agree about the efficacy of warfarin alone or warfarin plus low-dose aspirin in preventing recurrences of venous and arterial thrombosis, there is still doubt regarding the intensity and duration of warfarin therapy. Steroids and immunosuppressive drugs have not provided long- term benefit. Controlled clinical trials of the treatment of pregnant women with antiphospholipid antibody demonstrated that prednisolone is ineffective, and possibly detrimental, in treatment of recurrent pregnancy loss and that heparin plus low-dose aspirin is beneficial.

Key Words: anticardiolipin • lupus anticoagulant • treatment • prognosis

Lupus, Vol. 7, No. 2 suppl, S162-S165 (1998)
DOI: 10.1177/096120339800700235


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				N. C. T. Kong Pregnancy of a lupus patient--a challenge to the nephrologist Nephrol. Dial. Transplant., February 1, 2006; 21(2): 268 - 272. [Full Text] [PDF]

				R. L. Bick and D. Hoppensteadt Recurrent Miscarriage Syndrome and Infertility Due to Blood Coagulation Protein/Platelet Defects: A Review and Update Clinical and Applied Thrombosis/Hemostasis, January 1, 2005; 11(1): 1 - 13. [Abstract] [PDF]

				Y Shoenfeld and M Blank Autoantibodies associated with reproductive failure Lupus, September 1, 2004; 13(9): 643 - 648. [Abstract] [PDF]

				R Cervera and J Balasch The management of pregnant patients with antiphospholipid syndrome Lupus, September 1, 2004; 13(9): 683 - 687. [Abstract] [PDF]

				J Balasch and R Cervera Reflections on the management of reproductive failure in the antiphospholipid syndrome--the clinician's perspective Lupus, August 1, 2002; 11(8): 467 - 477. [Abstract] [PDF]

				M. Marietta, M. Bertesi, L. Simoni, I. Castelli, C. Cappi, and G. Torelli Cerebral Vein Thrombosis and Lupus Anticoagulant Antibodies Clinical and Applied Thrombosis/Hemostasis, July 1, 2001; 7(3): 238 - 238. [PDF]

				A N Malaviya and M Mourou Should low-dose aspirin also be a background therapy for all patients with systemic lupus erythematosus (SLE)? Lupus, September 1, 2000; 9(7): 561 - 562. [PDF]